Can-Fite BioPharma Ltd. (CANF) › Net IncomeCan-Fite BioPharma Ltd. (CANF) — Net IncomeAnnual figures by fiscal year, from SEC filings.2017: -$4.84M2018: -$6.57M2019: -$12.62M2020: -$14.44M2021: -$12.62M2022: -$10.17M2023: -$7.63M2024: -$7.88M2025: -$9.83M-$9.83M2017Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$9.83M-24.7%2024-$7.88M-3.2%2023-$7.63M+25.0%2022-$10.17M+19.4%2021-$12.62M+12.7%2020-$14.44M-14.4%2019-$12.62M-92.1%2018-$6.57M-35.7%2017-$4.84M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share